Enanta Pharmaceuticals
ENTA
$12.07
Share price
-6.00%
Change (1 day)
-49.96%
Change (1 year)
Categories
Enanta Pharmaceuticals (ENTA) - Net assets
Net assets on the balance sheet as of March 2024 : $0.16 B
According to Enanta Pharmaceuticals
's latest financial reports the company has $0.16 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Enanta Pharmaceuticals - Net assets on balance sheet (from 2011 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-09-30 | $0.21 B | -32.55% |
| 2022-09-30 | $0.32 B | -19.55% |
| 2021-09-30 | $0.39 B | -12.33% |
| 2020-09-30 | $0.45 B | -1.49% |
| 2019-09-30 | $0.46 B | 17.48% |
| 2018-09-30 | $0.39 B | 30.5% |
| 2017-09-30 | $0.30 B | 11.76% |
| 2016-09-30 | $0.26 B | 14.3% |
| 2015-09-30 | $0.23 B | 58.86% |
| 2014-09-30 | $0.14 B | 34.57% |
| 2013-09-30 | $0.11 B | 151.47% |
| 2012-09-30 | $43.92 M | 100.1% |
| 2011-09-30 | $21.95 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $70.02 B | 42,051.78% | 🇺🇸 USA |
 Novartis NVS | $39.75 B | 23,832.96% | 🇨🇭 Switzerland |
 AbbVie ABBV | $8.04 B | 4,744.26% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $18.54 B | 11,064.98% | 🇺🇸 USA |
 Merck MRK | $40.42 B | 24,235.10% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $16.54 B | 9,861.83% | 🇺🇸 USA |